Examinant per Autoria "Sancho, Juan Manuel"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Comparing R-Bendamustine vs. R-CHOP Plus maintenance therapy as first-line systemic treatment in follicular lymphoma: A multicenter retrospective GELTAMO study(MDPI, 2024) Bastos Oreiro, Mariana; Salar Silvestre, Antonio; Sancho, Juan Manuel
Ítem Accés Obert Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial(Ferrata Storti Foundation, 2024) Ribera, Josep Maria; Gimeno Vázquez, Eva; Sancho, Juan Manuel
Ítem Accés Obert HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era(Lippincott, Williams & Wilkins, 2015) Baptista, Maria Joao; García, Olga; Morgades, Mireia; González, Eva; Miralles, Eva; López Guillermo, Armando; Abella Monreal, Eugenia; Moreno, Miriam; Sancho, Juan Manuel; Feliu, Evarist; Ribera, Josep Maria; Navarro, José Tomás
Ítem Accés Obert IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice(Springer, 2022) Sancho, Juan Manuel; Salar Silvestre, Antonio; Rubio-Azpeitia, Eva
Ítem Accés Obert R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group(Wiley, 2021) Sancho, Juan Manuel; Fernández Alvarez, Rubén; Gual Capllonch, Francisco; González García, Esther; Grande, Carlos; Gutiérrez, Norma; Peñarrubia, María Jesús; Batlle López, Ana; González Barca, Eva; Guinea de Castro, José María; Gimeno Vázquez, Eva; Peñalver, Francisco-Javier; Fuertes, Miguel; Bastos Oreiro, Mariana; Hernández Rivas, José Ángel; Moraleda, José María; García, Olga; Sorigué, Marc; Martin, Alejandro
Ítem Accés Obert Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular Llymphoma after first-line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial(Wiley, 2019) Peñalver, Francisco-Javier; Márquez, José-Antonio; Durán, Soledad; Giraldo, Pilar; Martin, Alejandro; Montalbán, Carlos; Sancho, Juan Manuel; Ramírez, María-José; Terol, María-José; Capote, Francisco-Javier; Gutiérrez, Antonio; Sánchez González, Blanca; López, Andrés; Salar Silvestre, Antonio; Rodríguez-Caravaca, Gil; Canales, M.; Caballero, María Dolores; GELTAMO Group
Ítem Accés Obert Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity(American Society of Hematology, 2022) Fernández Rodríguez, M. Concepción; Rodríguez-Sevilla, Juan José; Fernández-Ibarrondo, Lierni; Sánchez González, Blanca; Gibert Fernandez, Joan, 1988-; Bento, Leyre; García, Juan Fernando; Sancho, Juan Manuel; Díez-Feijóo, Ramón; Camacho Díaz, Laura; García-Retortillo, Montserrat; Gimeno Vázquez, Eva; Colomo Saperas, Luis Alberto; Gutierrez, Antonio; Bellosillo Paricio, Beatriz; Salar Silvestre, Antonio